• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG ENDURO FEMORAL COMPONENT CEMENTED F1R; KNEE ENDOPROSTHESES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG ENDURO FEMORAL COMPONENT CEMENTED F1R; KNEE ENDOPROSTHESES Back to Search Results
Model Number NB017K
Device Problems Fracture (1260); Loosening of Implant Not Related to Bone-Ingrowth (4002)
Patient Problems Failure of Implant (1924); Patient Problem/Medical Problem (2688)
Event Date 08/07/2020
Event Type  Injury  
Manufacturer Narrative
Manufacturing site evaluation: investigation on-going.Additional information / investigation results will be provided in a supplemental report.
 
Event Description
It was reported that there was an issue with a enduro femoral component.According to the complaint description the femoral component fractured postoperatively.A revision surgery was necessary.Initial surgery: (b)(6) 2017.Revision surgery: (b)(6) 2020.The adverse event is filed under aag reference (b)(4).Involved components: nr400k - nut f/femur extens.Stem all sizes neutr.- lot 51836787, nr870m - enduro meniscal component f1 10mm - lot 51834047, nr292k - femur extens.Stem 6° d15x77mm cemented - lot 51858201.
 
Event Description
The adverse event is filed under aag reference (b)(4).
 
Manufacturer Narrative
Investigation results: visual investigation: the investigation was carried out visually and microscopically.On examination, it was found that the medial side of the femoral box and stem had compression marks indicating leverage of the stem.The medial side was under compression and the lateral side was under tension.The femoral component was implanted with wedges to correct the patient's bone defects.Neither the fracture surface of the femoral box (main fragment) nor that of the secondary fragment fragment shows material defects/abnormalities such as foreign body inclusions or blowholes.Both fracture surfaces show signs of fatigue fracture.No signs of hyperextension are visible on the enduro hinge ring.The sliding surface of the meniscus component shows small visible scratches and marks.This is due to third body wear caused by bone cement remnants cement residue and/or small bone fragments that have entered the gliding space between the femur and the meniscal component.Batch history review: the device quality and manufacturing history records have been checked for the available lot number and were found to be according to our specifications valid at the time of production.Review of the complaint history revealed that no similar complaints have been filed against products from this batch number.The review of risk assessment revealed that the overall risk level (severity x probability of occurrence) according to din en iso 14971 is still acceptable.Conclusion and measures / preventive measures: based upon the investigation results a clear root cause conclusion cannot be drawn.There is no indication for a material-, manufacturing- or design-related failure.Based upon the investigations results a capa is not necessary.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURO FEMORAL COMPONENT CEMENTED F1R
Type of Device
KNEE ENDOPROSTHESES
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
MDR Report Key10482863
MDR Text Key206960362
Report Number9610612-2020-00475
Device Sequence Number1
Product Code KRO
Combination Product (y/n)N
PMA/PMN Number
K101815
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 03/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/01/2017
Device Model NumberNB017K
Device Catalogue NumberNB017K
Device Lot Number51835982
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/31/2020
Date Manufacturer Received09/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
NR292K - 51858201; NR400K - 51836787; NR870M - 51834047
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-